SOA Professor’s Oral Biopsy Device Wins US Patent

oral-biopsy

A groundbreaking innovation in oral healthcare has emerged from Siksha ‘O’ Anusandhan (SOA) University, as Professor Neeta Mohanty, Pro Vice-Chancellor (Research & Collaboration), has successfully secured a US patent for her automated oral biopsy device. The pen-like device, designed to simplify and enhance biopsy procedures, is expected to transform the early detection and treatment of oral diseases, particularly oral cancer.

Revolutionizing Oral Biopsy Procedures
Biopsy remains the gold standard for diagnosing oral diseases, but traditional methods often require extensive instrumentation and skilled professionals. Prof. Mohanty’s automated device addresses these challenges by streamlining the biopsy process while ensuring accuracy and efficiency. With integrated tele-screening capabilities and fiber-optic lighting, the device enables better visualization and precision, minimizing the risk of erroneous or delayed diagnoses.

“Unskilled biopsy procedures frequently lead to misdiagnoses, delaying crucial treatment and sometimes resulting in life-threatening conditions. This device ensures early and accurate diagnosis while maintaining expert evaluation, thereby reducing the burden of oral diseases,” said Prof. Mohanty.

Recognition and Patent Achievements
The innovation has already received notable recognition. Prof. Mohanty initially filed for two Indian patents for the device in 2018, both of which were granted in 2023 and 2024. Additionally, she secured a design patent in 2019. Seeking global recognition, she applied for a US patent in 2019, which was published in 2020 and officially granted recently, marking a significant milestone in dental and medical research.

Her work has also earned her the prestigious Global Outreach Dental Innovation Award in 2021. Further showcasing its impact, the Science and Technology Department of the Odisha government selected the device for display at Global Bio India 2024 in New Delhi, a premier platform highlighting cutting-edge innovations in biotechnology and healthcare.

Support for Innovation and Future Prospects
The development of this breakthrough device was supported by funding from the Department of Science and Technology for prototype development. Recognizing its potential, Startup Odisha also approved the innovation for need-based assistance, further strengthening its path toward commercialization.

With oral cancer cases on the rise, particularly in India, Prof. Mohanty’s innovation holds immense promise in making early and accurate diagnosis more accessible. By integrating advanced technology with user-friendly functionality, the device is poised to revolutionize oral healthcare, ensuring timely interventions and improved patient outcomes.

Author

Leave a Reply

Your email address will not be published. Required fields are marked *